7Baggers
 NRXS Stock Declines Post Q3 Earnings Despite Continued Revenue Growth  Zacks Investment Research Mon, 17 Nov 2025 16:24:08 GMT
 NeurAxis, Inc. Reports Increased Sales Amidst Ongoing Losses  TipRanks Wed, 12 Nov 2025 04:13:48 GMT
 NeurAxis, Inc. Earnings Call: Growth Amid Challenges  TipRanks Wed, 12 Nov 2025 00:33:38 GMT
 Neuraxis reports Q3 revenue $811k vs $667k last year  TipRanks Tue, 11 Nov 2025 12:16:20 GMT
 NeurAxis (NASDAQ:NRXS) Stock Price Up 0.8% – What’s Next?  Defense World Tue, 11 Nov 2025 08:40:13 GMT

Neuraxis Inc.
(NYSE MKT:NRXS) 

NRXS stock logo

NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare ...

Founded: 2011
IPO Price: $6 (Aug 09, 2023)
Full Time Employees: 17
Sector: Biotechnology
Industry: Healthcare

Share this website to your friends